Exai Bio
Palo Alto
About Exai Bio
Exai Bio is a next-generation liquid biopsy company. Exai bio proprietary RNA and artificial intelligence-based liquid biopsy platform deliver clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $67.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2021)
- Website: exai.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/exai-bio-84101 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.